Literature DB >> 24905457

MCP-1 as a potential target to inhibit the bone invasion by oral squamous cell carcinoma.

Jingjing Quan1, Nigel A Morrison, Newell W Johnson, Jin Gao.   

Abstract

Bone invasion is a common complication of oral squamous cell carcinoma (OSCC), and this study sought to explore whether suppressed expression of monocyte chemotactic protein-1 (MCP-1) can be used to inhibit the bone invasion by OSCC. Strong staining of MCP-1 protein was observed from 10 archival blocks of OSCC by immunohistochemistry (IHC). Real-time PCR showed MCP-1 mRNA was highly expressed by OSCC cell lines (SCC25, HN5, and Tca8113), and SCC25 cells had the highest expression. An expression construct of a dominant negative variant of MCP-1 with 7 amino acids truncated (7ND), in the vector pcDNA was used to transfect SCC25 cells, and resultant stabilized SCC25 cells (SCC25-7ND) were generated by antibiotic selection. 10% conditioned media (CM, supernatant) of SCC25-7ND cells efficiently inhibited the formation of human osteoclasts grown from CD14(+) monocyte subpopulation, comparing with 10% CM of SCC25 cells. Further, cells of SCC25 or SCC25-7ND were injected onto the surface of calvariae of nude mice to establish an animal model of bone invasion by OSCC. H&E staining showed well-differentiated OSCC was formed in both groups, tumour cells invading the bone while osteoclasts locating in typical resorption lacunae. TRAP staining indicated significantly fewer osteoclasts were found in calvariae with cells of SCC25-7ND in comparison to cells of SCC25. These data demonstrate the relevance of MCP-1 with research on bone invasion by OSCC, and suggest the potential value of MCP-1 as a target to inhibit this common complication.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  BONE INVASION; MONOCYTE CHEMOTACTIC PROTEIN-1; ORAL SQUAMOUS CELL CARCINOMA; OSTEOCLASTS

Mesh:

Substances:

Year:  2014        PMID: 24905457     DOI: 10.1002/jcb.24849

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  12 in total

Review 1.  [Advances in molecular mechanisms of bone invasion by oral cancer].

Authors:  Wei Liu; Chun-Jie Li; Long-Jiang Li
Journal:  Hua Xi Kou Qiang Yi Xue Za Zhi       Date:  2021-04-01

2.  CCL28-induced RARβ expression inhibits oral squamous cell carcinoma bone invasion.

Authors:  Junhee Park; Xianglan Zhang; Sun Kyoung Lee; Na-Young Song; Seung Hwa Son; Ki Rim Kim; Jae Hoon Shim; Kwang-Kyun Park; Won-Yoon Chung
Journal:  J Clin Invest       Date:  2019-12-02       Impact factor: 14.808

3.  Monocyte Chemotactic Protein-1 (MCP1) Accumulation in Human Osteoclast Precursor Cultures.

Authors:  Nigel A Morrison; Mark R Forwood
Journal:  Life (Basel)       Date:  2022-05-26

4.  Utilization of E-cadherin by monocytes from tumour cells plays key roles in the progression of bone invasion by oral squamous cell carcinoma.

Authors:  Jingjing Quan; Qian Du; Yuluan Hou; Zhiyuan Wang; Jingyuan Zhang
Journal:  Oncol Rep       Date:  2017-06-23       Impact factor: 3.906

5.  Characterization of different osteoclast phenotypes in the progression of bone invasion by oral squamous cell carcinoma.

Authors:  Jingjing Quan; Yuluan Hou; Weiling Long; Shu Ye; Zhiyuan Wang
Journal:  Oncol Rep       Date:  2017-12-19       Impact factor: 3.906

Review 6.  Chemokines in Physiological and Pathological Bone Remodeling.

Authors:  Laura J Brylka; Thorsten Schinke
Journal:  Front Immunol       Date:  2019-09-13       Impact factor: 7.561

7.  Tumor necrosis factor alpha secreted from oral squamous cell carcinoma contributes to cancer pain and associated inflammation.

Authors:  Nicole N Scheff; Yi Ye; Aditi Bhattacharya; Justin MacRae; Dustin N Hickman; Atul K Sharma; John C Dolan; Brian L Schmidt
Journal:  Pain       Date:  2017-12       Impact factor: 7.926

8.  Mutant monocyte chemoattractant protein-1 protein (7ND) inhibits osteoclast differentiation and reduces oral squamous carcinoma cell bone invasion.

Authors:  Shuyu Luo; Chuanxiang Zhou; Jianming Zhang; Mengshan Chen; Hongjie Li; Shanchuan Zheng; Jingjing Quan
Journal:  Oncol Lett       Date:  2018-03-21       Impact factor: 2.967

Review 9.  Role of Tumor-Derived Chemokines in Osteolytic Bone Metastasis.

Authors:  Salvatore J Coniglio
Journal:  Front Endocrinol (Lausanne)       Date:  2018-06-07       Impact factor: 5.555

Review 10.  Monocyte Chemoattractant Protein-1 (MCP-1/CCL2) Drives Activation of Bone Remodelling and Skeletal Metastasis.

Authors:  Bridie S Mulholland; Mark R Forwood; Nigel A Morrison
Journal:  Curr Osteoporos Rep       Date:  2019-12       Impact factor: 5.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.